Varicella susceptibility and vaccination strategies in young adults
- PMID: 9719352
- DOI: 10.3122/jabfm.11.4.296
Varicella susceptibility and vaccination strategies in young adults
Abstract
Background: Varicella infection causes substantial morbidity in young adults. Most military basic trainees are 18 to 21 years old, yet the Army has no varicella vaccination policy. We therefore determined varicella susceptibility in a population of Army basic trainees, examined variables that might predict antibody status, and developed a vaccination strategies model.
Methods: Fifteen-hundred ninety-five trainees completed a demographic and historical questionnaire. Varicella antibody status was determined on 1201 volunteers. These data plus information from the literature were used to construct a decision tree of vaccination strategies that was applied to the total population of Army basic trainees in 1995 (n = 65,298).
Results: Fifty (4.2 percent) of 1201 soldiers were antibody negative. Trainees who lived with no or 1 sibling while growing up were most likely to be seronegative (P < 0.01). The positive predictive value of a history of varicella was 98.5 percent, whereas the negative predictive value of a negative history of varicella was 23 percent. In the vaccination strategies model, serologically testing soldiers with a negative history of varicella and vaccinating those without protective antibodies was the most cost-effective approach.
Conclusions: In young adults a positive varicella history accurately predicts immunity, but verification of a negative history with antibody testing is recommended before vaccination.
Similar articles
-
Cost effectiveness of vaccination strategies in adults without a history of chickenpox.Am J Med. 2000 Jun 15;108(9):723-9. doi: 10.1016/s0002-9343(00)00445-9. Am J Med. 2000. PMID: 10924649
-
Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection.Vaccine. 2017 Apr 25;35(18):2351-2357. doi: 10.1016/j.vaccine.2017.03.054. Epub 2017 Mar 27. Vaccine. 2017. PMID: 28359621
-
Clinical and economic impact of various strategies for varicella immunity screening and vaccination of health care personnel.Am J Infect Control. 2015 Oct 1;43(10):1053-60. doi: 10.1016/j.ajic.2015.05.027. Epub 2015 Jun 30. Am J Infect Control. 2015. PMID: 26138999
-
Clinical and economic considerations of vaccination against varicella.Pharmacotherapy. 1997 Jan-Feb;17(1):133-9. Pharmacotherapy. 1997. PMID: 9017774 Review.
-
Varicella vaccination guidelines for adolescents and adults.Am Fam Physician. 1997 Mar;55(4):1220-4. Am Fam Physician. 1997. PMID: 9092283 Review.
Cited by
-
Elderly immunocompetent man presenting with disseminated cutaneous herpes zoster.BMJ Case Rep. 2020 Aug 24;13(8):e237480. doi: 10.1136/bcr-2020-237480. BMJ Case Rep. 2020. PMID: 32843392 Free PMC article. No abstract available.
-
Herpes simplex virus-1 and varicella-zoster virus latency in ganglia.J Neurovirol. 2003 Apr;9(2):194-204. doi: 10.1080/13550280390194000. J Neurovirol. 2003. PMID: 12707850 Review.
-
Varicella vaccination--a critical review of the evidence.Arch Dis Child. 2001 Aug;85(2):83-90. doi: 10.1136/adc.85.2.83. Arch Dis Child. 2001. PMID: 11466178 Free PMC article. Review. No abstract available.
-
Distribution of herpes simplex virus type 1 and varicella zoster virus in ganglia of the human head and neck.J Infect Dis. 2009 Dec 15;200(12):1901-6. doi: 10.1086/648474. J Infect Dis. 2009. PMID: 19919304 Free PMC article.
-
An economic analysis of varicella immunization in the Singapore military.Mil Med Res. 2016 Feb 3;3:3. doi: 10.1186/s40779-016-0070-9. eCollection 2016. Mil Med Res. 2016. PMID: 26843963 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical